预测瘤外科手术中的术后并发症使用修改后的脆弱指数
Eduardo Espinoza-Prado1, Julio Jauregui1, Alanna Hickey2
1Universidad Cientifica del Sur, Lima, Peru.
The Journal of surgical research
|July 16, 2025
概括
修改后的5项脆弱性指数 (mFI) 识别了乳腺癌患者在瘤整形手术后出现并发症的风险较高. 一个mFI得分为2或以上显著增加了整体,医疗和伤口并发症的可能性.
科学领域:
- 瘤塑性手术是一项瘤塑性手术.
- 手术瘤学手术瘤学
- 患者的治疗结果.
背景情况:
- 术前评估对于接受瘤塑性手术的乳腺癌患者至关重要.
- 修改后的5项脆弱性指数 (mFI) 是用于预测术后并发症的验证工具.
- 这项研究评估了mFI在瘤性乳腺癌手术的实用性.
研究的目的:
- 评估修改后5项脆弱性指数 (mFI) 在预测乳腺癌患者进行瘤整形手术的术后并发症方面的有效性.
- 确定MFI得分与特定类型的并发症之间的关联,包括整体,医疗和伤口并发症.
主要方法:
- 来自国家外科质量改善计划数据库 (2005-2020) 的数据分析.
- 包括接受瘤塑性手术的乳腺癌患者.
- 基于mFI分数 (0,1和≥2) 和多变量逻辑回归来确定并发症风险因素的患者分层.
主要成果:
- 较高的mFI分数 (≥2) 与整体并发症 (7.7%),医疗并发症 (1.7%) 和伤口并发症 (4.4%) 的增加率有关.
- 多变量分析证实mFI ≥2是整体 (OR=1.67),医疗 (OR=5.24) 和伤口并发症 (OR=1.73) 的重要危险因素.
- 在mFI 0和mFI 1患者之间没有观察到结果的显著差异.
结论:
- 一个mFI分数为2或更高是一个强有力的预测器增加整体,医疗和伤口并发症在瘤性乳腺癌手术后.
- 具有mFI分数为1的患者经历的结果与具有mFI分数为0.0的患者相似.
- 对于高mFI分数 (≥2) 的患者,建议进行手术前咨询和量身定制的管理策略.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
380
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
16.7K
相关概念视频
Peripheral Artery Disease V: Postoperative Nursing Management
26
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
26
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
